RGS16 and central nervous system cancer: Recent studies have identified various molecules for both therapeutic targets and prognostic predictors in gliomas, including RGS16, NLR, TMEM7, SLAMF8, LINC00152, and NUSAP1.27, 28, 29, 30, 31, 32, 33